TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
Today Sen. Paul took to the senate floor to shame his colleagues about not debating and voting for war before sending young Americans to fight in foreign countries. “Nobody wanted to have this debate,” Paul said. “They want to rubber stamp… and they want to send your kids to war with no debate.” (For the Read More…
Despite the recognition that Carl Jung has received throughout the last century or so, the importance of his work still cannot be stressed enough. The real beauty of Jung’s work was his ability to conceptualize a variety of esoteric, even shamanistic concepts through scientific, empirical observation. While some might still beg to differ, Jung’s concepts Read More…
Abstract: Contrary to reports in the media, the crowd sourced investigation labeled by some as “Pizzagate” did not begin with internet sleuths digging through the WikiLeaks Podesta Files releases looking for pizza parlors and encoded language discussing human trafficking. It began with the shocking discovery that Hillary and Bill Clinton provided assistance to convicted child trafficker, Read More…
Let’s suppose there really is such a thing as The Thinking Class in this country, if it’s not too politically incorrect to say so – since it implies that there is another class, perhaps larger, that operates only on some limbic lizard-brain level of impulse and emotion. Personally, I believe there is such a Thinking Read More…
(RT) Over the past couple of weeks almost 20 black and Latina girls have gone missing in Washington, DC. The disappearances have gained little or no attention from mainstream media. Regardless of one’s stance on the ongoing investigation into the prevalence of pedophilia within the government and positions of authority, the fact that the media Read More…
After it waged a veritable war against cannabis legalization in Arizona, coughing up half a million dollars for the campaign, Insys Therapeutics recently announced the ultimate victory has finally come to fruition: the DEA approved one of the company’s groundbreaking pharmaceuticals — synthetic marijuana — to be listed as a Schedule II substance. “Insys gave $500,000 last Read More…